Position in BSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,070,951
New position
Shares Held
957,306
first reported quarter
Ownership
0.064%
of shares outstanding
% of Portfolio
2.90%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Derivatives in BSX
reported options exposure · as of Mar 31, 2026CallValue
$31,375,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Mar 31, 2026Longaeva Partners L.P. holds $91,741,786 across 6 Medical Devices names. BSX ranks #1 (65.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
This page
|
957,306 | $60,070,951 | |
| 2 | DXCM |
Dexcom Inc
|
135,000 | $8,478,000 | |
| 3 | INSP |
Inspire Medical Systems, Inc.
|
138,761 | $7,157,292 | |
| 4 | TMDX |
TransMedics Group, Inc.
|
69,057 | $6,864,956 | |
| 5 | LMRI |
Lumexa Imaging Holdings, Inc.
|
557,423 | $4,793,837 | |
| 6 | PRCT |
PROCEPT BioRobotics Corp
|
175,000 | $4,376,750 |
All Filings in BSX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,375,000 | 500,000 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $60,070,951 | 957,306 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||